Moleculin Biotech to Execute Reverse Stock Split

The company will consolidate its shares at a 1-for-20 ratio beginning October 20, 2026.

Updated on Oct. 16, 2026 in Corporate Finance

Isometric editorial illustration showing twenty small glass spheres merging into one larger sphere, representing a corporate share consolidation. — Moleculin Biotech will implement a 1-for-20 reverse stock split on October 20, 2026, consolidating its outstanding common shares. AI Illustration. Upload story photo >

Live Poll

Do you view a reverse stock split as a negative signal for a company's financial future?

Moleculin Biotech will initiate a 1-for-20 reverse stock split on October 20, 2026, as part of an amendment to its certificate of incorporation. The consolidation will reduce the company's outstanding common shares from approximately 20.9 million to 1.05 million.

Why it matters

The reduction in share count is a structural adjustment for the Houston-based company, which has stated it will require significant additional financing to continue its clinical trials. The move keeps authorized shares at 500 million while consolidating the existing float.

The split applies a 1-for-20 ratio to all outstanding common shares, which will trade under the existing MBRX ticker with a new CUSIP number. The nominal par value per share will remain at $0.001 following the transition.

The players

Moleculin Biotech

This Houston-based clinical-stage pharmaceutical company focuses on developing drug candidates for the treatment of cancer and other serious diseases.

The Nasdaq Capital Market

This is a global electronic marketplace for buying and selling securities that lists thousands of publicly traded companies.

The details

Moleculin Biotech filed the amendment in Delaware to consolidate its outstanding equity, ensuring stockholders receive cash payments in lieu of fractional shares. The stock will continue to trade on The Nasdaq Capital Market following the implementation of the new share structure.

The reverse stock split takes effect at 12:01 am on October 20, 2026.

Market Dynamics

This reverse stock split aligns with historical patterns used by companies to maintain compliance with Nasdaq listing maintenance standards. Such structural adjustments are frequently employed to manage share price levels in the broader macroeconomic environment.

Shareholders will see their total share count reduced by a factor of 20, with fractional shares converted into cash payments. Investors should update their records to reflect the new CUSIP number for the MBRX ticker following the October 20 effective date.

The takeaway

Investors should note that reverse splits do not change the underlying market capitalization of the firm but do consolidate the total number of shares in circulation. Holders should verify their portfolio balances after the conversion date to account for the new share totals.